Related Experiment Video

Updated: Aug 7, 2026

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy
08:34

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy

Published on: September 25, 2017

[Surgical treatment of hypertropic obstructive cardiomyopathy]

M E Rothlin

    Schweizerische Medizinische Wochenschrift
    |March 5, 1977
    PubMed

    Insights

    Surgery for hypertrophic obstructive cardiomyopathy effectively relieves symptoms by eliminating the left ventricular outflow tract pressure gradient. While complications like mitral incompetence can be cured, surgical treatment only slows, not halts, the underlying cardiomyopathy progression.

    Area of Science:

    • Cardiology
    • Cardiovascular Surgery

    Background:

    • Hypertrophic obstructive cardiomyopathy (HOCM) presents complex hemodynamic alterations, including dynamic systolic obstruction (muscular subaortic stenosis) and potential diastolic filling issues.
    • The precise impact of pressure load from subaortic stenosis on left ventricular compliance via secondary hypertrophy remains under investigation.

    Purpose of the Study:

    • To discuss the clinical presentation and pathogenesis of hemodynamic alterations in HOCM.
    • To evaluate the long-term efficacy of surgical intervention for HOCM.

    Main Methods:

    • Review of clinical findings and pathogenetic mechanisms in HOCM.
    • Analysis of the late clinical course in 28 patients who underwent surgical treatment for HOCM.

    Main Results:

    • Surgical intervention successfully abolishes the left ventricular outflow tract pressure gradient, leading to sustained symptom relief.
    • Complications associated with obstructive hypertrophic cardiomyopathy, including mitral incompetence, were resolved through surgery.
    • While surgical treatment appears to slow the progression of cardiomyopathy, it does not arrest it.

    Conclusions:

    • Surgical treatment offers significant symptomatic improvement and resolution of specific complications in HOCM patients.
    • The underlying disease progression in hypertrophic obstructive cardiomyopathy is only partially affected by surgical intervention.

    More Related Videos

    Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy07:02

    Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

    Published on: September 9, 2020

    A Surgical Method for Subvalvular Structure Intervention Through a Transaortic Approach in Normal Bama Pigs07:24

    A Surgical Method for Subvalvular Structure Intervention Through a Transaortic Approach in Normal Bama Pigs

    Published on: March 13, 2026

    Related Concept Videos

    Mitral Stenosis III: Medical Management01:26

    Mitral Stenosis III: Medical Management

    Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

    Cardiomyopathy IV: Restrictive Cardiomyopathy

    Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

    Cardiomyopathy VII: Pre and Post Operative Nursing Management

    Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...